Tuberculosis treatment outcomes: Directly observed therapy compared with self-administered therapy

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 5, 2004, Pages 561-566

  Jasmer, Robert M ^a   Seaman, Christopher B ^b   Gonzalez, Leah C ^b   Kawamura, L Masae ^b   Osmond, Dennis H ^b   Daley, Charles L ^b  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Directly observed therapy; Epidemiology; Pulmonary tuberculosis

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIRECTLY OBSERVED THERAPY; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; ANTITUBERCULAR AGENTS; DIRECTLY OBSERVED THERAPY; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RECURRENCE; SAN FRANCISCO; SELF ADMINISTRATION; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 4444229460     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200401-095OC     Document Type: Article

References (20)

1. American Thoracic Society and Centers for Disease Control. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994;149:1359-1374.
2. Weis SE, Slocum PC, Blais FX, King B, Nunn M, Matney GB, Gomez E, Foresman BH. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994;330:1179-1184.
3. Burman WJ, Cohn DL, Rietmeijer CA, Judson FN, Sbarbaro JA, Reves RR. Noncompliance with directly observed therapy for tuberculosis: epidemiology and effect on the outcome of treatment. Chest 1997;111:1168-1173.
4. Maher D, Chaulet P, Spinaci S, Harries A. Treatment of tuberculosis: guidelines for national programmes, 2nd ed. Geneva: WHO, 1997.
5. Enarson DA, Rieder HL, Arnadottir T, Trebucq A. Management of tuberculosis: a guide for low income countries, 5th ed. Paris: International Union Against Tuberculosis and Lung Disease, 2000.
6. American Thoracic Society/Centers for Disease Control and Prevention/ Infectious Diseases Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-662.
7. Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis. JAMA 1995;274:945-951.
8. Alwood K, Keruly J, Moore-Rice K, Stanton DL, Chaulk CP, Chaisson RE. Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients. AIDS 1994;8:1103-1108.
9. Driver CR, Munsiff SS, Li J, Kundamal N, Osahan SS. Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City. Clin Infect Dis 2001;33:1762-1769.
10. Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ, Tatley M. Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet 1998;352:1340-1343.
11. Walley JD, Khan MA, Newell JN, Khan MH. Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan. Lancet 2001;357:664-669.
12. Kamolratanakul P, Sawer H, Lertmaharit S, Kasctjaroen Y, Akksilp S, Tulaporn C, Punnachest K, Na-Songkhla S, Payanandana V. Randomized controlled trial of directly observed therapy for patients with tuberculosis in Thailand. Trans R Soc Trop Med Hyg 1999;93:552-557.
13. Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ, Tatley M. A randomised controlled trial of lay health workers as direct observers for treatment of tuberculosis. Int J Tuberc Lung Dis 2000;4:550-554.
14. Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis. Consensus statement of the public health tuberculosis guidelines panel. JAMA 1998;279:943-948.
15. Jasmer RM, Seaman CB, Gonzalez LC, Kawamura LM, Daley CL. Treatment outcomes among pulmonary tuberculosis patients treated by directly observed therapy compared with self-administered therapy. Am J Respir Crit Care Med 2003;167:A868.
16. California Department of Health Services. Report on tuberculosis in California, 2000. August 2001:17.
17. Aber VR, Nunn AJ. Factors affecting relapse following short-course chemotherapy. Bull Int Union Tuberc 1978;53:260-264.
18. Zierski M, Bek E. Long MW, Snider DE. Short-course (6-month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment. Am Rev Respir Dis 1980;122:879-889.
19. Mitchison DA. Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months. Am Rev Respir Dis 1993;147:1062-1063.
20. Tuberculosis Trials Consortium. Rifapentine and isoniazid once a week versus rifampin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis: a randomized clinical trial. Lancet 2002;360:528-534.